1 Objectives: To evaluate renal expression of C4d, a complement component in the 2 classical/mannose binding lectin (MBL) pathway, in patients with primary Sjögren's 3 syndrome (pSS)-associated renal impairments. 4 Methods: We retrospectively reviewed the clinical and pathological data from 39 patients 5 with pSS presenting with renal impairments. C4d was examined in paraffin-embedded 6 biopsy tissues using immunohistochemistry. Glomerular C4d positive was defined 7
The kidney is affected in approximately 0.3% to 33.5% of patients with primary Sjögren's 2 syndrome (pSS), a systemic disease characterized by sicca symptoms and anti-Ro/SSA and/or 3 anti-La/SSB antibodies (Francois &Mariette, 2016; Garcia-Carrasco et al., 2002; Ramos-Casals 4 et al., 2014) . Two main pathological entities have been described. Tubular interstitial nephritis 5 (TIN) is the major type and is often characterized by renal tubular acidosis (RTA) with or 6 without renal insufficiency (Evans et al., 2016) . Glomerulonephritis (GMN) is the other type, different studies (Carrillo-Pérez et al., 2018; Francois &Mariette, 2016) . (predominantly IgG4 and C3 deposition) (Sinico et al., 2016) . PMN is characterized by the A positive control for C4d was obtained from dendritic lymphocytes in human tonsil 1 8 tissues from a patient undergoing an operation for obstructive sleep apnoea hypopnea 1 9 syndrome( Fig S1) (Zwirner et al., 1989) . Renal tissues from patients with mild lesions who 2 0 underwent a biopsy for microscopic haematuria were used as negative controls ( Fig S2) . 2 Tubulointerstitial C4d (TI-C4d) deposition was semi-quantitatively scored as 0 (absent), 1 3 (weak or spotty stain), 2 (patchy stain), and 3 (diffuse stain) within microscopic fields. A TI-4 C4d score >1 was defined as positive (TI-C4d + ) (Tan et al., 2011) . Using a TI-C4d deposit 5 score of >1 as a cut-off, patients were classified into the TI-C4d + TI-C4dgroups.
6
Peritubular capillary C4d (PTC-C4d) staining was evaluated and graded according to the 7 Banff criteria as negative (0, absent), minimal (1, less than 10%), focal (2, between 10% and 8 50%) and diffuse (3, >50%) (Haas et al., 2014) . Continuous variables with a normal distribution were analysed using Student's t-test or the was considered statistically significant. Calculations were performed using SPSS statistical 1 6 software version 11.5 (SPSS, Chicago, IL, USA). Among the 39 patients included in this study, 21 were diagnosed with TIN, and 18 were 2 1 diagnosed with GMN. Eight of 18 patients with GMN also had TIN. The male:female ratio 1 was 9:30. The average age of the patients was 42±14.1 (9-72) years at the time of renal 2 biopsy. ANA was positive in 37/39 patients, with different titres: 8 patients at a 1:1280 titre, 8 3 patients at 1:640, 9 patients at 1:320, 9 patients at 1:160, 2 patients at 1:80, and 1 patient at 4 1:40. Hyper-γ-globulinemia was present in 11/36 (28.2%) patients. Elevated serum Ig levels 5 and hypocomplementemia were also observed ( IgAN and 3 with MCD. Twenty-one patients were diagnosed with TIN. Specifically, 2 1 9 patients were diagnosed with acute interstitial nephritis, and the other 19 were diagnosed with 2 0 chronic interstitial nephritis. in mesangium (Fig 2 A, B ). IF staining revealed IgG deposition in 7/8 of patients with MN 2 3 and C3 deposition in 2/8 of patients with MN. Only 1 patient displayed weak C1q deposition 1 0 using IF staining. Sub-epithelial electron-dense deposits (EDDs) and occasional mesangial 1 EDDs were also observed in patients with MN using EM, including the patient with negative 2 IgG deposition, confirming the diagnosis of MN (Table 2) . Six of the patients with MN were 3 diagnosed with stage II-III disease and exhibited different degrees of mesangial proliferation.
4
Four cases had segmental thickening of GBM. Three out of five patients with MePGN and 1/2 5 patients with IgAN had mild mesangial deposition of C4d, but the staining area did not meet 6 the criteria for glomerular C4d positive (Fig 2 C) . IgG or C3 deposition. Immune complex deposition was relatively rare in patients with TIN.
Four patients with TIN exhibited tubular and interstitial deposition of IgG and C3.
1 5
We compared the clinical and pathological characteristics between the tubulointerstitial 1 6
C4d-positive group (TI-C4d score >1) and C4d-negative group (Table 3) . TI-C4d-positive 1 7
patients experienced a longer duration of renal involvement (P=0.001) and exhibited 1 8 increased serum creatinine levels at kidney biopsy (P=0.008). TI-C4d score had a linear 1 9
correlation with serum creatinine levels at kidney biopsy (β=17.5±6.92, P=0.016).
0
Pathologically, the TI-C4d + group exhibited a higher interstitial fibrosis score (P=0.035) 2 1 (Table 3 ). The TI-C4d score exhibited weak correlations with the percentage of sclerotic another and cyclophosphamide in the other two). Two of them were followed for more than 1 7
half a year and did not exhibit a significant improvement of renal function. In one patient, Scr and different from SLE-MN(Kim &Jeong, 2003) , the underlying mechanism remains to be 1 7
investigated.
1 8
The significance of tubulointerstitial C4d deposition is not clear, and few studies are be explored in a prospective study with large sample size.
4
The retrospective nature of this study may lead to possible bias, as more patients with 1 5 GMN were listed in the kidney biopsy database. Other limitations of our study were that we 1 6 1 6 involvement of the MBL pathway of complement activation in pSS-renal lesions.
1 Tubulointerstitial C4d deposits might be a candidate of pathological markers of severe renal 2 injury in patients with pSS-related renal impairments, which remains to be further 3 investigated. were scored according to the percentage of interstitial area involved: 0 (absent), 1 (≤25%), 2 8 (25-50%), 3 (50%-75%), and 4 (>75%). 
